×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
CNTA – centessa pharmaceuticals plc - american depositary shares (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
CNTA
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
11/15
02:08 pm
cnta
Centessa Pharmaceuticals plc (NASDAQ: CNTA) had its price target raised by analysts at Guggenheim from $24.00 to $28.00. They now have a "buy" rating on the stock.
Medium
Report
Centessa Pharmaceuticals plc (NASDAQ: CNTA) had its price target raised by analysts at Guggenheim from $24.00 to $28.00. They now have a "buy" rating on the stock.
11/12
07:00 am
cnta
Centessa Pharmaceuticals Reports Financial Results for the Third Quarter of 2024 and Provides Business Update
Low
Report
Centessa Pharmaceuticals Reports Financial Results for the Third Quarter of 2024 and Provides Business Update
11/4
07:30 am
cnta
Centessa Pharmaceuticals to Participate in Upcoming Investor Conferences
Low
Report
Centessa Pharmaceuticals to Participate in Upcoming Investor Conferences
9/26
06:00 am
cnta
Centessa Pharmaceuticals Presents Preclinical Data for ORX142, a Novel Orexin Receptor 2 (OX2R) Agonist, at the 27th Congress of the European Sleep Research Society (Sleep Europe 2024)
Low
Report
Centessa Pharmaceuticals Presents Preclinical Data for ORX142, a Novel Orexin Receptor 2 (OX2R) Agonist, at the 27th Congress of the European Sleep Research Society (Sleep Europe 2024)
9/19
07:05 pm
cnta
Centessa Pharmaceuticals plc (NASDAQ: CNTA) was upgraded by analysts at Morgan Stanley from an "equal weight" rating to an "overweight" rating. They now have a $26.00 price target on the stock, up previously from $11.00.
Low
Report
Centessa Pharmaceuticals plc (NASDAQ: CNTA) was upgraded by analysts at Morgan Stanley from an "equal weight" rating to an "overweight" rating. They now have a $26.00 price target on the stock, up previously from $11.00.
9/19
07:58 am
cnta
Centessa Pharmaceuticals plc (NASDAQ: CNTA) is now covered by analysts at B. Riley. They set a "buy" rating and a $33.00 price target on the stock.
Low
Report
Centessa Pharmaceuticals plc (NASDAQ: CNTA) is now covered by analysts at B. Riley. They set a "buy" rating and a $33.00 price target on the stock.
9/16
09:13 am
cnta
Centessa Pharmaceuticals plc (NASDAQ: CNTA) had its price target raised by analysts at BMO Capital Markets from $20.00 to $35.00. They now have an "outperform" rating on the stock.
Low
Report
Centessa Pharmaceuticals plc (NASDAQ: CNTA) had its price target raised by analysts at BMO Capital Markets from $20.00 to $35.00. They now have an "outperform" rating on the stock.
9/12
10:41 pm
cnta
Centessa Pharmaceuticals Announces Pricing of Upsized $225,000,000 Public Offering of American Depositary Shares [Yahoo! Finance]
High
Report
Centessa Pharmaceuticals Announces Pricing of Upsized $225,000,000 Public Offering of American Depositary Shares [Yahoo! Finance]
Date
Time
Symbol
Company Name
Action
%Chg
11/12/2024
07:00 am
cnta
centessa pharmaceuticals plc - american depositary shares
BEAT
Report
1.6%
centessa pharmaceuticals plc - american depositary shares
8/13/2024
07:00 am
cnta
centessa pharmaceuticals plc - american depositary shares
MISS
Report
4.4%
centessa pharmaceuticals plc - american depositary shares
8/13/2024
07:00 am
cnta
centessa pharmaceuticals plc - american depositary shares
MISS
Report
5.7%
centessa pharmaceuticals plc - american depositary shares
5/13/2024
04:10 pm
cnta
centessa pharmaceuticals plc - american depositary shares
BEAT
Report
2.4%
centessa pharmaceuticals plc - american depositary shares
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
11/20
04:03 pm
cnta
Form 144 Centessa Pharmaceuticals Filed by: SAHA SAURABH
Medium
Report
Form 144 Centessa Pharmaceuticals Filed by: SAHA SAURABH
11/15
04:31 pm
cnta
Form 4 Centessa Pharmaceuticals For: Nov 13 Filed by: SAHA SAURABH
Low
Report
Form 4 Centessa Pharmaceuticals For: Nov 13 Filed by: SAHA SAURABH
11/14
05:44 pm
cnta
Form SC 13G/A Centessa Pharmaceuticals Filed by: EcoR1 Capital, LLC
Medium
Report
Form SC 13G/A Centessa Pharmaceuticals Filed by: EcoR1 Capital, LLC
11/14
04:21 pm
cnta
Form SC 13G/A Centessa Pharmaceuticals Filed by: BIOTECHNOLOGY VALUE FUND L P
Medium
Report
Form SC 13G/A Centessa Pharmaceuticals Filed by: BIOTECHNOLOGY VALUE FUND L P
11/13
04:19 pm
cnta
Form 144 Centessa Pharmaceuticals Filed by: SAHA SAURABH
Medium
Report
Form 144 Centessa Pharmaceuticals Filed by: SAHA SAURABH
11/12
09:24 am
cnta
Form 8-K Centessa Pharmaceuticals For: Nov 12
Low
Report
Form 8-K Centessa Pharmaceuticals For: Nov 12
11/12
09:22 am
cnta
Form 10-Q Centessa Pharmaceuticals For: Sep 30
Low
Report
Form 10-Q Centessa Pharmaceuticals For: Sep 30
10/25
07:20 pm
cnta
Form 4 Centessa Pharmaceuticals For: Oct 25 Filed by: Weinhoff Gregory M
Low
Report
Form 4 Centessa Pharmaceuticals For: Oct 25 Filed by: Weinhoff Gregory M
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: